Changes in depression ratings and regional glucose uptake before and after treatment. by José V. Pardo (8293983)

Possible scenarios explaining a changing Impact Factor (IF). by Tobias Kiesslich (292510)

“…<p>(A) Based on theoretical considerations regarding the potential influence of the variables (citations and article numbers) on the final calculation (i.e. the IF quotient), 13 scenarios are possible which either cause an increased (a1-a5), constant (b1-b3) or decreased IF (c1-c3). …”

Summary statistics of main outcomes. by Anita Svadzian (15927140)

“…To assess the difference in case management and the use of drugs across the two cases by round, a difference in difference (DiD) model was employed. …”

Summary statistics of main outcomes by case. by Anita Svadzian (15927140)

“…To assess the difference in case management and the use of drugs across the two cases by round, a difference in difference (DiD) model was employed. …”

Standardised patient case descriptions. by Anita Svadzian (15927140)

“…To assess the difference in case management and the use of drugs across the two cases by round, a difference in difference (DiD) model was employed. …”

FIGURE 6 from D-2-HG Inhibits <i>IDH1^mut</i> Glioma Growth via FTO Inhibition and Resultant m6A Hypermethylation by Sean T. Pianka (18237413)

“…<p>ATF5 is a downstream mediator of the <i>IDH1^mut</i> → D-2-HG ⊣ FTO axis leading to gliomasphere growth reduction. …”

BMT has long term effects on white adipose tissue. by Saeed Katiraei (3956147)

“…<p>(A) Weight of sWAT and vWAT pads was decreased in BMT-treated mice as compared to control mice. …”

Mechanical indices in the femoral bones of wildtype and diabetic mice. by Mishaela R. Rubin (2637448)

Analyze data. by Xinhui Zhang (1624039)

“…Compared with the Sham surgery group, there was a significant decrease in NeuN over time (P < 0.01) and a significant increase in IBA-1 and CIRBP (P < 0.01) in the severe injury group. …”

Mouse spinal cord injury strike parame. by Xinhui Zhang (1624039)

“…Compared with the Sham surgery group, there was a significant decrease in NeuN over time (P < 0.01) and a significant increase in IBA-1 and CIRBP (P < 0.01) in the severe injury group. …”

Image_5_Myricetin, the Main Flavonoid in Syzygium cumini Leaf, Is a Novel Inhibitor of Platelet Thiol Isomerases PDI and ERp5.tif by Renato Simões Gaspar (8384040)

“…Additionally, myricetin is a novel inhibitor of ERp5 and PDI, unveiling a new therapeutic perspective for the treatment of thrombotic disorders.…”

Image_5_Myricetin, the Main Flavonoid in Syzygium cumini Leaf, Is a Novel Inhibitor of Platelet Thiol Isomerases PDI and ERp5.tif by Renato Simões Gaspar (8384040)

“…Additionally, myricetin is a novel inhibitor of ERp5 and PDI, unveiling a new therapeutic perspective for the treatment of thrombotic disorders.…”

Table_5_Two DNA Methyltransferases for Site-Specific 6mA and 5mC DNA Modification in Xanthomonas euvesicatoria.XLSX by Hye-Jee Park (3594245)

“…Xe(XvDMT2) was more tolerant to EtOH than Xe(XvDMT1), which had enhanced tolerance to sorbitol but decreased tolerance to polymyxin B. Using single-molecule real-time sequencing and methylation-sensitive restriction enzymes, we successfully predicted putative motifs methylated by XvDMT1 and XvDMT2, which are previously uncharacterized 6mA and 5mC DNA MTases, respectively. …”

Risk of bias assessment for studies included in the systematic review using a modified version of the risk of bias criteria for interrupted time series studies, suggested by the Co... by Bruna Rubbo (287422)

Constructing the T10 spinal cord injury model. by Xinhui Zhang (1624039)

Expression of genes involved in five different neurotransmitter phenotypes. by Joanna A. Korecka (415952)

“…<p>Genes involved in neurotransmitter phenotypes are indicated in undifferentiated (noRA) and RA differentiated (RA) SH-SY5Y cells for: serotonin (<b>A</b>), noradreneline (<b>B</b>), histamine (<b>D</b>), acetylcholine (<b>E</b>) and glutamate (<b>F</b>) phenotype. …”

DataSheet_1_Effects of immunophilin inhibitors and non-immunosuppressive analogs on coronavirus replication in human infection models.pdf by Emilia J. Berthold (13839388)

“…</p>Results<p>Both CsA and ALV robustly inhibited viral replication in all models; both compounds decreased HCoV-229E RNA in phBECs and reduced luminescence in HCoV-229E-RLuc-infected Huh7.5 and SARS-CoV-1-RLuc replicon-transfected HEK293. …”

SPR-based analysis of the interaction of non-specific his-tagged proteins (<i>Pf</i>MSP1) with <i>Pf</i>HtrA2-PDZ as control set; the sensorgrams were obtained by flowing increasin... by Shweta Singh (409313)

Table2_The involvement of the noradrenergic system in the antinociceptive effect of cucurbitacin D on mice with paclitaxel-induced neuropathic pain.docx by Keun-Tae Park (14326092)

“…Cucurbitacin D treatment significantly decreased the spinal α₁- but not α₂-adrenergic receptors, and the amount of spinal noradrenaline was also downregulated. …”

datasheet3_Resolvin D1 ameliorates Inflammation-Mediated Blood-Brain Barrier Disruption After Subarachnoid Hemorrhage in rats by Modulating A20 and NLRP3 Inflammasome.zip by Chengcong Wei (10077199)

“…The expression of endogenous RVD1 was decreased whereas A20 and NLRP3 levels were increased after SAH. …”